Loading...
Scholar Rock Holding Corporation
SRRK•NASDAQ
Healthcare
Biotechnology
$38.95
$-0.16(-0.41%)
Scholar Rock Holding Corporation (SRRK) Financial Performance & Income Statement Overview
Review Scholar Rock Holding Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-47.15%
↓ 47.15%
Net Income Growth
-48.56%
↓ 48.56%
Operating Cash Flow Growth
-38.37%
↓ 38.37%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-118.22%
↓ 118.22%
ROIC
-73.17%
↓ 73.17%
Scholar Rock Holding Corporation (SRRK) Income Statement & Financial Overview
Review Scholar Rock Holding Corporation's (SRRK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $498000.00 | $598000.00 |
| Gross Profit | $0.00 | $0.00 | -$498000.00 | -$598000.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $49.97M | $48.72M | $42.37M | $42.50M |
| SG&A Expenses | $18.99M | $16.06M | $17.13M | $15.32M |
| Operating Expenses | $69.36M | $64.78M | $59.50M | $57.82M |
| Total Costs & Expenses | $69.36M | $64.78M | $59.50M | $58.42M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $395000.00 | $446000.00 | $498000.00 | $598000.00 |
| EBITDA | -$68.96M | -$64.33M | -$59.00M | -$57.82M |
| EBITDA Ratio | ||||
| Operating Income | -$69.36M | -$64.78M | -$59.50M | -$58.42M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $2.90M | $301000.00 | $990000.00 | $1.57M |
| Income Before Tax | -$66.45M | -$64.48M | -$58.51M | -$56.85M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $554724.00 |
| Net Income | -$66.45M | -$64.48M | -$58.51M | -$56.85M |
| Net Income Ratio | ||||
| EPS | -$0.67 | -$0.66 | -$0.60 | -$0.59 |
| Diluted EPS | -$0.67 | -$0.66 | -$0.60 | -$0.59 |
| Weighted Avg Shares Outstanding | $93.82M | $97.05M | $96.81M | $95.89M |
| Weighted Avg Shares Outstanding (Diluted) | $93.82M | $97.05M | $96.81M | $95.89M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan